Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Xenotransplantation. 2015 Jun 1;22(4):295–301. doi: 10.1111/xen.12172

Fig. 1.

Fig. 1

IL-4- and IL-13-protected ECs and control ECs exhibit similar loss of permeability control upon incubation with complement. ECs were incubated with various doses of IL-4 (A) or IL-13 (B) for 48 h, washed and incubated with 7.5% human serum for 2 h. Then the % LDH released in the supernatants and the % killing (cells that failed to take up neutral red) were measured. Results are means ± S.E.M. of 4 experiments (A) and 3 experiments (B) that were performed in triplicate. LDH release vs. killing, p < 0.01 for all doses of IL-4 and IL-13 tested.